Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 CHF | -3.00% |
|
-19.07% | +97.38% |
06-20 | Top Premarket Gainers | MT |
06-17 | Transcript : Molecular Partners AG Presents at TD Cowen 2nd Annual Radiopharmaceutical Innovation Summit, Jun-17-2024 10:40 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+97.38% | 260M | |
+16.27% | 122B | |
+21.43% | 116B | |
+22.18% | 27.03B | |
-21.86% | 20.36B | |
-16.89% | 16.43B | |
-18.50% | 15.91B | |
-44.74% | 15.6B | |
+61.65% | 14.94B | |
+2.88% | 13.59B |
- Stock Market
- Equities
- MOLN Stock
- News Molecular Partners AG
- Molecular Partners Gears Up for 2024 Milestones, Including Data From Leukemia Treatment Trial